Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04054752
Title Vaccine Response With NT-I7
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Her2-receptor positive breast cancer

breast carcinoma

bladder carcinoma

estrogen-receptor positive breast cancer

colorectal adenocarcinoma

progesterone-receptor positive breast cancer

Therapies

NT-I7

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.